Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7-chloro-3-methyl-3,4-dihydro-2h-1,2,4-benzothiadiazine-s,s-dioxide
2. Idra 21
3. Idra-21
1. 22503-72-6
2. Idra-21
3. Idra 21
4. 7-chloro-3-methyl-3,4-dihydro-2h-benzo[e][1,2,4]thiadiazine 1,1-dioxide
5. 7-chloro-3,4-dihydro-3-methyl-2h-1,2,4-benzothiadiazine 1,1-dioxide
6. 689uw7pt68
7. 163936-78-5
8. 7-chloro-3-methyl-3,4-dihydro-2h-1,2,4-benzothiadiazine S,s-dioxide
9. 7-chloro-3-methyl-3-4-dihydro-2h-1,2,4 Benzothiadiazine S,s-dioxide
10. 2h-1,2,4-benzothiadiazine, 7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide
11. 7-chloro-3-methyl-3,4-dihydro-2h-benzo(e)(1,2,4)thiadiazine 1,1-dioxide
12. (+)-idra-21
13. (-)-idra-21
14. Biomol-nt_000225
15. Idra21
16. Chembl77862
17. Schembl195328
18. Unii-689uw7pt68
19. Bpbio1_001088
20. Gtpl4219
21. Dtxsid70936887
22. Ex-a737
23. Chebi:111162
24. Hms3267d13
25. Hms3412o19
26. Hms3676o19
27. Bcp19065
28. Xaa50372
29. 7-chloro-3-methyl-3,4-dihydro-2h-1,2,4-benzothiadiazine-s,s-dioxide
30. Hb0334
31. Mfcd00270874
32. S2434
33. 2h-1,2,4-benzothiadiazine,7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide
34. Akos024456473
35. Idra 21, >=98%
36. 2h-1,2,4-benzothiadiazine, 7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide, (+)-
37. 2h-1,2,4-benzothiadiazine, 7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide, (-)-
38. Ncgc00025050-02
39. 163936-79-6
40. Ds-11824
41. Hy-101528
42. Cs-0021632
43. Ft-0700269
44. A878525
45. Sr-01000597374
46. J-014742
47. Q5970086
48. Sr-01000597374-1
49. Brd-a14344385-001-01-6
50. Brd-a14344385-001-02-4
51. 7-chloro-3-methyl-3,4-dihydro-2h-1,2,4-benzothiadiazine
52. S 18986;s18986;idra-21;idra21;idra 21;ampakine
53. 7-chloro-3-methyl-3,4-dihydro-2h-1$l^{6},2,4-benzothiadiazine-1,1-dione
54. 2h-1,2,4-benzothiadiazine,7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide; Idra 21
55. 7-chloro-3-methyl-3,4-dihydro-1lambda~6~,2,4-benzothiadiazine-1,1(2h)-dione
56. 7-chloro-3-methyl-3,4-dihydro-2h-1lambda6,2,4-benzothiadiazine 1,1-dioxide
| Molecular Weight | 232.69 g/mol |
|---|---|
| Molecular Formula | C8H9ClN2O2S |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 66.6 |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 314 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Ampakine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ampakine, including repackagers and relabelers. The FDA regulates Ampakine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ampakine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ampakine supplier is an individual or a company that provides Ampakine active pharmaceutical ingredient (API) or Ampakine finished formulations upon request. The Ampakine suppliers may include Ampakine API manufacturers, exporters, distributors and traders.
Ampakine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ampakine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ampakine GMP manufacturer or Ampakine GMP API supplier for your needs.
A Ampakine CoA (Certificate of Analysis) is a formal document that attests to Ampakine's compliance with Ampakine specifications and serves as a tool for batch-level quality control.
Ampakine CoA mostly includes findings from lab analyses of a specific batch. For each Ampakine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ampakine may be tested according to a variety of international standards, such as European Pharmacopoeia (Ampakine EP), Ampakine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ampakine USP).
LOOKING FOR A SUPPLIER?
